Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis
Open Access
- 26 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (10) , 1962-1973
Abstract
Plastin 3 (PLS3), encoded by PLS3 , is a newly recognized regulator of bone metabolism and mutations in the encoding gene result in severe childhood‐onset osteoporosis. Since an X chromosomal gene, PLS3 mutation‐positive males are typically more severely affected while females portray normal to increased skeletal fragility. Despite the severe skeletal pathology, conventional metabolic bone markers tend to be normal and are thus insufficient in diagnosing or monitoring patients. Our study aimed to explore serum microRNA (miRNA) concentrations in subjects with defective PLS3 function to identify novel markers that could differentiate subjects according to mutation status and give insight into the molecular mechanisms by which PLS3 regulates skeletal health. We analyzed fasting serum samples for a custom‐designed panel comprising 192 miRNAs in 15 mutation‐positive (5 males, age range 8–76 years, median 41 years) and 14 mutation‐negative (6 males, 8–69 years, 40 years) subjects from four Finnish families with different PLS3 mutations. We identified a unique miRNA expression profile in the mutation‐positive subjects with seven significantly up‐ or downregulated miRNAs (miR‐93‐3p, miR‐532‐3p, miR‐133a‐3p, miR‐301b‐3p, miR‐181c‐5p, miR‐203a‐3p, miR‐590‐3p; p ‐values 0.004–0.044). Surprisingly, gender subgroup analysis revealed the difference to be even more distinct in female mutation‐positive subjects (congruent p‐ values 0.007–0.086) than in males (p ‐values 0.127–0.843) in comparison to corresponding mutation‐negative subjects. While the seven identified miRNAs have all been linked to bone metabolism and two of them (miR‐181c‐5p and miR‐203a‐3p) have bioinformatically predicted targets in PLS3 3’UTR, none have previously been reported to associate with PLS3. Our results indicate that PLS3 mutations are reflected in altered serum miRNA levels and suggest there to be crosstalk between PLS3 and these miRNAs in bone metabolism. These provide new understanding of the pathomechanisms by which mutations in PLS3 lead to skeletal disease and may provide novel avenues for exploring miRNAs as biomarkers in PLS3 osteoporosis or as target molecules in future therapeutic applications.Keywords
Funding Information
- Barncancerfonden
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Helsingin Yliopisto
- Helsingin Yliopiston Tiedesäätiö
- Karolinska Institutet
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Lastentautien Tutkimussäätiö
- Novo Nordisk
- Orionin Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
- Samfundet Folkhälsan
- Sigrid Juséliuksen Säätiö
- Stockholms Läns Landsting
- Suomen Akatemia
- Vetenskapsrådet
- Barncancerfonden
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Helsingin Yliopisto
- Helsingin Yliopiston Tiedesäätiö
- Karolinska Institutet
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Lastentautien Tutkimussäätiö
- Novo Nordisk
- Orionin Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
- Samfundet Folkhälsan
- Sigrid Juséliuksen Säätiö
- Stockholms Läns Landsting
- Research Council of Finland
- Vetenskapsrådet
This publication has 53 references indexed in Scilit:
- WNT signaling in bone homeostasis and disease: from human mutations to treatmentsNature Medicine, 2013
- MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in MedulloblastomaJournal of Biological Chemistry, 2013
- Assessing sample and miRNA profile quality in serum and plasma or other biofluidsMethods, 2013
- miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer CellsJournal of Biological Chemistry, 2012
- MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal OsteoporosisPLOS ONE, 2012
- MicroRNA control of bone formation and homeostasisNature Reviews Endocrinology, 2012
- Genetics of OsteoporosisEndocrine Reviews, 2010
- Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular AtrophyScience, 2008
- Human MicroRNA TargetsPLOS Biology, 2004
- MicroRNAsCell, 2004